Clinical Trial Update: Real-world Study on the Management of Hematological Toxicities Associated With Targeted Therapies for Breast Cancer

View source ↗

Summary

A real-world study sponsored by Fudan University aims to evaluate management strategies for hematological toxicities arising from targeted therapies in breast c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Fudan University | Conditions: Hematological Toxicity, Targeted Therapy | Status: RECRUITING